Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JTT-705 (dalcetrapib) plus atorvastatin in patients with low HDL-C
NCT00689442Phase 2Completed
- Sponsor
- Akros Pharma Inc.
- Start
- Jan 2004
- Primary completion
- Nov 2004
- Countries
- 1
01
Overview
A Phase 2 trial of dalcetrapib in dyslipidemia, sponsored by Akros Pharma Inc.. Started Jan 2004; status: completed.
02
Drugs
dalcetrapib
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT00689442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00689442.